Molecular alterations underlying Doxorubicin’s Chronic Cardiotoxicity in a mouse model

Authors

• Sofia Reis Brandão Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; UCIBIO-Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal; LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
• Ana Reis-Mendes Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; UCIBIO-Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
• Margarida Duarte-Araújo Department of Immuno-Physiology and Pharmacology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal.
• Maria João Neuparth Research Centre in Physical Activity, Health and Leisure (CIAFEL), Faculty of Sports, University of Porto, Porto, Portugal; TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU CRL, Gandra, Portugal.
• Félix Carvalho Associate Laboratory i4HB - Institute for Health and Bioeconomy
• Rita Ferreira LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
• Vera Marisa Costa Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal; UCIBIO-Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.